PBS Website Update - 1 May 2022

The Schedule of Pharmaceutical Benefits was updated on 1 May 2022 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website.

• Drugs subject to Price Disclosure - 1 May 2022
• Ex-manufacturer price - 1 May 2022
• Formulary Allocations - 1 May 2022
• Medicine Status Website - 1 May 2022
• Recommendations made by the PBAC - March 2022 - 22 April 2022
• Health Products Portal Industry Webinars - 14 April 2022
• Health Products Portal - Quick Reference Guides - 14 April 2022
• Fact sheet – Requesting a change to an existing price - 14 April 2022
• PBAC Public Summary Documents (first time decisions not to recommend, deferrals and other matters) – December 2021 meeting - 14 April 2022
• PBS and RPBS Section 85 Date of Supply Data - 13 April 2022
• Access to Medicines Working Group – February 2022 - 11 April 2022
• Reference Committee for the Health Technology Assessment Policy and Methods Review - 10 April 2022
• Paxlovid® (nirmatrelvir and ritonavir) PBS listing - 9 April 2022
• PBAC Recommendation for nirmatrelvir and ritonavir (Paxlovid®) March 2022 - 9 April 2022
• Clarity about Supply Only arrangements - 5 April 2022
• Consultation now open - review of base case discount rate at 3A.1 of the PBAC guidelines - 5 April 2022
• Post-market Review of Opiate Dependence Treatment Program (ODTP) Medicines - 4 April 2022
• PBAC Public Summary Documents – December 2021 meeting - 1 April 2022
• Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 April 2022